Scinai Immunotherapeutics Ltd Asset Turnover Ratio (SCNI), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Scinai Immunotherapeutics Ltd  (NASDAQ: SCNI)
 

Scinai Immunotherapeutics Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Scinai Immunotherapeutics Ltd asset turnover ratio, the ability of Scinai Immunotherapeutics Ltd's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.08 in the fourth quarter (Dec 31 2025), yet the ratio remained below the average, as SCNI's position remain challenging.

Within sector 54 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from to 3559.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SCNI Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Asset Change 650.7 % -20.6 % -68.85 % -38.87 % -74.09 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.08 - - - -
SCNI's Total Ranking # 3559 # # # #
Seq. Asset Change 266.62 % -16.83 % 19.03 % 106.84 % -61.22 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 55
Healthcare Sector # 515
Overall Market # 3559

Asset Turnover Ratio Statistics
High Average Low
0.11 0.11 0.11
(Dec 31 2025)  




SCNI Company Profile • Back to SCNI Efficiency Comparisons • Compare SCNI Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Beam Therapeutics Inc   0.10 $ 139.743  Millions$ 1,412.584  Millions
Viridian Therapeutics Inc   0.10 $ 70.835  Millions$ 719.985  Millions
Sintx Technologies Inc   0.10 $ 1.018  Millions$ 10.379  Millions
Eyepoint Inc   0.10 $ 31.371  Millions$ 319.851  Millions
Metagenomi Therapeutics Inc   0.10 $ 25.210  Millions$ 259.798  Millions
Kura Oncology Inc   0.10 $ 67.482  Millions$ 703.483  Millions
Renovorx Inc   0.09 $ 1.123  Millions$ 12.240  Millions
Bicycle Therapeutics Plc  0.09 $ 72.586  Millions$ 799.407  Millions
Insight Molecular Diagnostics Inc   0.09 $ 4.055  Millions$ 45.143  Millions
Polomar Health Services, Inc.  0.09 $ 0.648  Millions$ 7.225  Millions
Septerna Inc   0.09 $ 45.951  Millions$ 513.023  Millions
Nyxoah Sa  0.08 $ 11.085  Millions$ 132.688  Millions
Ocugen Inc   0.08 $ 4.413  Millions$ 54.792  Millions
Nano X Imaging Ltd  0.08 $ 13.021  Millions$ 162.165  Millions
Prophase Labs Inc   0.08 $ 4.339  Millions$ 54.431  Millions
Therapeuticsmd Inc   0.08 $ 3.022  Millions$ 38.267  Millions
Ovid Therapeutics Inc   0.08 $ 7.252  Millions$ 93.466  Millions
Longeveron Inc   0.08 $ 1.199  Millions$ 15.854  Millions
Intellia Therapeutics Inc   0.07 $ 67.671  Millions$ 913.115  Millions
Concord Medical Services Holdings Ltd  0.07 $ 65.852  Millions$ 936.260  Millions
Precigen Inc   0.07 $ 9.684  Millions$ 139.363  Millions
Safe Pro Group Inc   0.07 $ 0.607  Millions$ 9.009  Millions
Cytokinetics Incorporated  0.07 $ 88.039  Millions$ 1,337.695  Millions
Protagonist Therapeutics inc   0.07 $ 46.016  Millions$ 707.504  Millions
Nexalin Technology Inc   0.06 $ 0.302  Millions$ 4.806  Millions
Agape Atp Corporation  0.06 $ 1.524  Millions$ 24.722  Millions
Omniab Inc   0.06 $ 18.666  Millions$ 303.115  Millions
Vir Biotechnology Inc   0.06 $ 68.556  Millions$ 1,130.634  Millions
Alector Inc   0.06 $ 21.045  Millions$ 348.312  Millions
Entrada Therapeutics Inc   0.06 $ 25.421  Millions$ 431.385  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.